Uroprotective effects of curcumin in cyclophosphamide-induced haemorrhagic cystitis paradigm

Basic and Clinical Pharmacology and Toxicology

Volumn 104, Issue 5, 2009, Pages 393-399

  Arafa, Hossam M M ^a  

^a Al Azhar University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CURCUMIN; CYCLOPHOSPHAMIDE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; MYELOPEROXIDASE; NITRATE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DESQUAMATION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; EDEMA; ENZYME ACTIVITY; EXTRAVASATION; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HYPOKALEMIA; HYPONATREMIA; INFLAMMATION; LAMINA PROPRIA; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; UROTHELIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CURCUMIN; CYCLOPHOSPHAMIDE; CYSTITIS; HEMORRHAGE; MALE; MICE; NITRIC OXIDE; POTASSIUM; SODIUM; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER; UROTHELIUM;

RATTUS;

EID: 64549130896     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00379.x     Document Type: Article

References (48)

1. Jurado García JM, Sánchez A, Pajares B, Pérez E, Alonso L, Alba E. Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer. Clin Transl Oncol 2008 10 : 583 6.
2. Ip EJ, Lee-Ma A, Troxell LS, Chan J. Low-dose filgrastim in patients with breast cancer treated with docetaxel, doxorubicin, and cyclophosphamide. Am J Health Syst Pharm 2008 65 : 1552 5.
3. Kopterides P, Theodorakopoulou M, Mentzelopoulos S, Armaganidis A. Cyclophosphamide-induced hemorrhagic cystitis successfully treated with conjugated estrogens. Am J Hematol 2005 80 : 166 7.
4. Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A et al. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen. Biol Blood Marrow Transplant 2008 14 : 43 9.
5. Brock N, Pohl J, Stekar J. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 1. Experimental studies on the urotoxicity of alkylating compounds. Eur J Cancer 1981 17 : 595 607.
6. Gomes TN, Santos CC, Souza-Filho MV, Cunha FQ, Ribeiro RA. Participation of TNF-alpha and IL-1 in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Braz J Med Biol Res 1995 28 : 1103 8.
7. Topal T, Oztas Y, Korkmaz A, Sadir S, Oter S, Coskun O et al. Melatonin ameliorates bladder damage induced by cyclophosphamide in rats. J Pineal Res 2005 38 : 272 7.
8. Korkmaz A, Kurt B, Yildirim I, Basal S, Topal T, Sadir S et al. Effects of poly(ADP-ribose) polymerase inhibition in bladder damage caused by cyclophosphamide in rats. Exp Biol Med (Maywood) 2008 233 : 338 43.
9. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991 57 : 1 7.
10. Ak T, Gülçin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact 2008 174 : 27 37.
11. Meghana K, Sanjeev G, Ramesh B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Eur J Pharmacol 2005 577 : 183 91.
12. Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol 2008 14 : 2003 9.
13. Jacob A, Wu R, Zhou M, Wang P. Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-gamma Activation. PPAR Res 2007 23 : 89369.
14. Wolters G, Kuijpers LP, Kacaki J, Shuurs AH. Enzyme-linked immunosorbent assay for hepatitis B surface antigen. Enzyme-linked immunosorbent assay for hepatitis B surface antigen. J Infect Dis 1977 136 : S311 7.
15. Wong ST, Spoo J, Kerst KC, Spring TG. Colorimetric determination of potassium in whole blood, serum, and plasma. Clin Chem 1985 31 : 1464 7.
16. Berry MN, Mazzachi RD, Pejakovic M, Peake MJ. Enzymatic determination of sodium in serum. Clin Chem 1988 34 : 2295 8.
17. Manktelow A, Meyer A. Lack of correlation between decreases chemotaxis and susceptibility to infection in burned rats. J Trauma 1986 26 : 143 148.
18. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001 5 : 62 71.
19. Adams, H. Adenosine 5′-triphosphate determination with phosphoglycerate kinase. In : Bergmeyer HU (ed.). Method of Enzymatic Analysis. New York : Academic, 1963 539 543.
20. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959 74 : 214 226.
21. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974 249 : 7130 9.
22. Uchiyama M, Mihara K. Determination of malondialdehyde precursor in tissue by thiobarbituric acid test. Anal Biochem. 1978 86 : 271 278.
23. Hu RQ, Mehter H, Nadasdy T, Satoskar A, Spetie DN, Rovin BH et al. Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review. Rheumatol Int 2008 28 : 1161 4.
24. Sadir S, Deveci S, Korkmaz A, Oter S. Alpha-tocopherol, beta-carotene and melatonin administration protects cyclophosphamide-induced oxidative damage to bladder tissue in rats. Cell Biochem Funct 2007 25 : 521 6.
25. Chow YC, Yang S, Huang CJ, Tzen CY, Su YH, Wang PS. Prophylactic intravesical instillation of epinephrine prevents cyclophosphamide-induced hemorrhagic cystitis in rats. Exp Biol Med (Maywood) 2007 232 : 565 70.
26. Matsuoka Y, Masuda H, Yokoyama M, Kihara K. Protective effects of bilirubin against cyclophosphamide induced hemorrhagic cystitis in rats. J Urol 2008 179 : 1160 6.
27. Malley SE, Vizzard MA. Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis. Physiol Genomics 2002 9 : 5 13.
28. Lieber IH, Stoneburner SD, Floyd M, McGuffin WL. Potassium-wasting nephropathy secondary to chemotherapy simulating Bartter's syndrome. Cancer 1984 54 : 808 10.
29. Wong TM, Yeo W, Chan LW, Mok TS. Hemorrhagic pyelitis, ureteritis, and cystitis secondary to cyclophosphamide: case report and review of the literature. Gynecol Oncol 2000 76 : 223 5.
30. Linares-Fernández BE, Alfieri AB. Cyclophosphamide induced cystitis: role of nitric oxide synthase, cyclooxygenase-1 and 2, and NK(1) receptors. J Urol 2007 177 : 1531 6.
31. Dang K, Lamb K, Cohen M, Bielefeldt K, Gebhart GF. Cyclophosphamide- induced bladder inflammation sensitizes and enhances P2X receptor function in rat bladder sensory neurons. J Neurophysiol 2008 99 : 49 59.
32. Andersson MC, Tobin G, Giglio D. Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat. Br J Pharmacol 2008 153 : 1438 44.
33. Xu X, Cubeddu LX, Malave A. Expression of inducible nitric oxide synthase in primary culture of rat bladder smooth muscle cells by plasma from cyclophosphamide-treated rats. Eur J Pharmacol 2001 416 : 1 9.
34. Manesh C, Kuttan G. Effect of naturally occurring isothiocyanates in the inhibition of cyclophosphamide-induced urotoxicity. Phytomedicine 2005 12 : 487 93.
35. Sheeja K, Kuttan G. Protective effect of Andrographis paniculata and andrographolide on cyclophosphamide-induced urothelial toxicity. Integr Cancer Ther 2006 5 : 244 51.
36. Zhong S, Huang M, Yang X, Liang L, Wang Y, Romkes M et al. Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus. Br J Clin Pharmacol 2006 62 : 457 72.
37. Gulcubuk A, Altunatmaz K, Sonmez K, Haktanir-Yatkin D, Uzun H, Gurel A et al. Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis. J Vet Med A Physiol Pathol Clin Med 2006 53 : 49 54.
38. Reyes-Gordillo K, Segovia J, Shibayama M, Vergara P, Moreno MG, Muriel P. Curcumin protects against acute liver damage in the rat by inhibiting NF-kappa B, proinflammatory cytokines production and oxidative stress. Biochim Biophys Acta 2007 1770 : 989 96.
39. Babu PS, Srinivasan K. Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 1995 152 : 13 21.
40. Punithavathi D, Venkatesan N, Babu M. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br J Pharmacol 2003 139 : 1342 50.
41. Deguchi Y, Andoh A, Inatomi O, Yagi Y, Bamba S, Araki Y et al. Curcumin prevents the development of dextran sulfate Sodium (DSS)-induced experimental colitis. Dig Dis Sci 2007 52 : 2993 8.
42. Jung KK, Lee HS, Cho JY, Shin WC, Rhee MH, Kim TG et al. Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia. Life Sci 2006 79 : 2022 31.
43. Zheng J, Ramirez VD. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br J Pharmacol 2000 130 : 1115 23.
44. Shukla PK, Khanna VK, Khan MY, Srimal RC. Protective effect of curcumin against lead neurotoxicity in rat. Hum Exp Toxicol 2003 22 : 653 8.
45. Ali BH, Al-Wabel N, Mahmoud O, Mousa HM, Hashad M. Curcumin has a palliative action on gentamicin-induced nephrotoxicity in rats. Fundam Clin Pharmacol 2005 19 : 473 7.
46. Ye SF, Hou ZQ, Zhong LM, Zhang QQ. Effect of curcumin on the induction of glutathione S-transferases and NADP(H): quinone oxidoreductase and its possible mechanism of action. Yao Xue Xue Bao 2007 42 : 376 80.
47. Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 2005 11 : BR228 34.
48. Jain SK, Rains J, Jones K. Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radic Biol Med 2006 41 : 92 6.